PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −15 vs. Q4 2024
- Shares held
- 37.3M
- −1.64M (−4.2%) vs. Q4 2024
- Total value
- $40.7M
- −$18.2M (−30.9%) vs. Q4 2024
- New holders
- 1
- 9 more added
- Sold out
- 16
- 32 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,475,291 | $7.06M | 0.17% | 00.0% | Unchanged |
| BML Capital Management, LLC | 3,747,612 | $4.08M | 3.31% | +280,928+8.1% | Added |
| Sio Capital Management, LLC | 3,735,396 | $4.07M | 1.23% | +163,229+4.6% | Added |
| ArrowMark Colorado Holdings LLC | 3,308,677 | $3.61M | 0.06% | −199,774−5.7% | Reduced |
| PFM Health Sciences, LP | 3,301,942 | $3.60M | 0.28% | +1,222,697+58.8% | Added |
| Euclidean Capital LLC | 2,627,643 | $2.86M | 1.08% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 2,342,373 | $2.55M | 0.02% | −1,358−0.1% | Reduced |
| Vanguard Group Inc | 2,175,061 | $2.37M | 0.00% | +31,959+1.5% | Added |
| Acadian Asset Management LLC | 2,047,177 | $2.23M | 0.01% | −31,689−1.5% | Reduced |
| BlackRock, Inc. | 1,144,396 | $1.25M | 0.00% | −2,088−0.2% | Reduced |
| D. E. Shaw & Co., Inc. | 949,726 | $1.04M | 0.00% | −74,562−7.3% | Reduced |
| Stonepine Capital Management, LLC | 630,183 | $686.9K | 0.80% | +94,378+17.6% | Added |
| Aldebaran Capital, LLC | 523,553 | $570.7K | 0.54% | +21,363+4.3% | Added |
| Two Sigma Advisers, LP | 505,600 | $551.1K | 0.00% | −209,000−29.2% | Reduced |
| Peapod Lane Capital LLC | 489,370 | $533.4K | 0.60% | +43,626+9.8% | Added |
| Geode Capital Management, LLC | 430,792 | $469.7K | 0.00% | +9,082+2.2% | Added |
| Two Sigma Investments, LP | 353,227 | $385.0K | 0.00% | −153,759−30.3% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 267,636 | $291.7K | 0.00% | −103,284−27.8% | Reduced |
| RBF Capital, LLC | 245,561 | $267.7K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 157,578 | $171.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 155,389 | $169.4K | 0.00% | −162,631−51.1% | Reduced |
| UBS Group AG | 152,283 | $166.0K | 0.00% | −123,181−44.7% | Reduced |
| Bridgeway Capital Management, LLC | 148,800 | $162.2K | 0.00% | −53,300−26.4% | Reduced |
| Evoke Wealth, LLC | 133,122 | $145.1K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 129,914 | $141.6K | 0.00% | −409,979−75.9% | Reduced |
| Dimensional Fund Advisors LP | 126,004 | $137.4K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 115,038 | $125.4K | 0.00% | −38,663−25.2% | Reduced |
| Northern Trust Corp | 107,346 | $117.0K | 0.00% | +60.0% | Added |
| Walleye Capital LLC | 101,696 | $110.8K | 0.00% | −25,930−20.3% | Reduced |
| ADAR1 Capital Management, LLC | 101,008 | $110.1K | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 90,263 | $98.4K | 0.00% | −30,982−25.6% | Reduced |
| Panagora Asset Management Inc | 89,631 | $97.7K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 62,134 | $67.7K | 0.00% | −6,979−10.1% | Reduced |
| Velan Capital Investment Management LP | 35,000 | $38.1K | 0.04% | 00.0% | Unchanged |
| Bank of America Corp | 34,706 | $37.8K | 0.00% | −9,862−22.1% | Reduced |
| Price T Rowe Associates Inc | 33,600 | $37.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 30,197 | $32.9K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 30,891 | $32.7K | 0.00% | −8,189−21.0% | Reduced |
| Morgan Stanley | 28,066 | $30.6K | 0.00% | −13,697−32.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 22,900 | $25.0K | 0.00% | −12,300−34.9% | Reduced |
| Squarepoint Ops LLC | 21,896 | $23.9K | 0.00% | −51,119−70.0% | Reduced |
| Citigroup Inc | 19,310 | $21.0K | 0.00% | −495,601−96.2% | Reduced |
| Ameriprise Financial Inc | 18,007 | $19.6K | 0.00% | −4,800−21.0% | Reduced |
| Citadel Advisors LLC | 14,120 | $15.4K | 0.00% | −93,768−86.9% | Reduced |
| Independent Advisor Alliance | 12,500 | $13.6K | 0.00% | −14−0.1% | Reduced |
| JPMorgan Chase & Co | 11,449 | $12.5K | 0.00% | −13,142−53.4% | Reduced |
| Group One Trading, L.P. | 11,296 | $12.3K | 0.00% | −3,687−24.6% | Reduced |
| CI Private Wealth, LLC | 10,000 | $10.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,000 | $10.9K | 0.00% | +10,000 | New |
| Public Employees Retirement System of Ohio | 2,092 | $2.28K | 0.00% | −2,846−57.6% | Reduced |
| Jones Financial Companies LLLP | 1,000 | $1.11K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 720 | $785 | 0.00% | −805−52.8% | Reduced |
| BNP Paribas Arbitrage, SA | 544 | $593 | 0.00% | −219−28.7% | Reduced |
| FMR LLC | 315 | $343 | 0.00% | −690−68.7% | Reduced |
| Royal Bank of Canada | 384 | $0 | 0.00% | −40,000−99.0% | Reduced |
| M&T Bank Corp | 0 | $0 | 0.00% | −399,548−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −322,024−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −156,451−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −64,009−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −49,870−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −32,603−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −28,700−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −24,880−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16,935−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,014−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,877−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,034−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,595−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,320−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −105−100.0% | Sold out |